Literature DB >> 30408554

Peptide-based targeted therapeutics: Focus on cancer treatment.

Fatemeh Araste1, Khalil Abnous2, Maryam Hashemi3, Seyed Mohammad Taghdisi4, Mohammad Ramezani5, Mona Alibolandi6.   

Abstract

Therapeutic peptides are attracting increasing attention for biomedical applications. Peptides present promising opportunities in targeted drug delivery due to their high specificity, selectivity, small dimensions, ease of modification, and high biocompatibility. During the last decade, the potential of peptides as therapeutics or targeting ligands has been boomed in nanotechnology and cancer research. This review summarizes various peptides as therapeutics and targeting ligands in cancer therapy. At first, two categories of tumor homing and cell penetrating peptides (CPPs) are introduced and then we will discuss the modification of CPPs. Then various types of tumor targeting peptides and their applications in cancer research are represented.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer therapy; Cell penetrating peptides; Peptides; Tumor homing peptide

Mesh:

Substances:

Year:  2018        PMID: 30408554     DOI: 10.1016/j.jconrel.2018.11.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  19 in total

1.  C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway.

Authors:  Mingyuan Zhao; Yinhe Wang; Yan Liu; Wanchun Zhang; Yakun Liu; Xiaoming Yang; Yunxia Cao; Siying Wang
Journal:  Cancer Biol Ther       Date:  2019-08-23       Impact factor: 4.742

2.  Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma.

Authors:  Kuancan Liu; Fuan Xie; Tingting Zhao; Rui Zhang; Anding Gao; Yunyun Chen; Haiyan Li; Shihui Zhang; Zhangwu Xiao; Jieping Li; Xiaoqian Hong; Lei Shang; Weifeng Huang; Junkai Wang; Wael El-Rifai; Alexander Zaika; Xi Chen; Jianwen Que; Xiaopeng Lan
Journal:  Mol Ther       Date:  2020-01-15       Impact factor: 11.454

3.  Examination of the impact molecular charge has on NTSR1-targeted agents incorporated with cysteine protease inhibitors.

Authors:  Wei Fan; Wenting Zhang; Sameer Alshehri; Jered C Garrison
Journal:  Eur J Med Chem       Date:  2022-03-08       Impact factor: 6.514

4.  CPP Applications in Immune Modulation and Disease Therapy.

Authors:  Ja-Hyun Koo; Won-Ju Kim; Je-Min Choi
Journal:  Methods Mol Biol       Date:  2022

5.  Development of D-melittin polymeric nanoparticles for anti-cancer treatment.

Authors:  Shixian Lv; Meilyn Sylvestre; Kefan Song; Suzie H Pun
Journal:  Biomaterials       Date:  2021-08-23       Impact factor: 15.304

6.  Preparation and Characterization of Quantum Dot-Peptide Conjugates Based on Polyhistidine Tags.

Authors:  Katherine D Krause; Hsin-Yun Tsai; Kelly Rees; Hyungki Kim; W Russ Algar
Journal:  Methods Mol Biol       Date:  2021

Review 7.  Homing Peptides for Cancer Therapy.

Authors:  Prakash Lingasamy; Tambet Teesalu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Harnessing molecular recognition for localized drug delivery.

Authors:  Renjie Liu; Ran Zuo; Gregory A Hudalla
Journal:  Adv Drug Deliv Rev       Date:  2021-01-20       Impact factor: 15.470

Review 9.  Peptides that immunoactivate the tumor microenvironment.

Authors:  Natsuki Furukawa; Aleksander S Popel
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-01       Impact factor: 10.680

10.  Glycosylation of a Nonfibrillizing Appendage Alters the Self-Assembly Pathway of a Synthetic β-Sheet Fibrillizing Peptide.

Authors:  Ran Zuo; Renjie Liu; Juanpablo Olguin; Gregory A Hudalla
Journal:  J Phys Chem B       Date:  2021-06-15       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.